APVO

Conviction 36HealthcareScan · Thu, Jun 25, 2026

APVO$4.65-1.90%

ResistanceSupportVol 14

Vol MA14 16.27K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Aptevo Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.aptevotherapeutics.com ↗

Price4.65

Change-1.90%

Gap-3.48%

Rel volume0.83×

Avg volume30.39K

Avg $ vol149.8K

SMA 204.82

SMA 504.91

SMA 2004.15

Price vs 50-5.32%

Price vs 200+11.97%

MA stackmixed

50/200 cross—

Supertrendup · 4.39

RSI (14)46

MACD hist-0.01

MACD cross—

Stoch %K / %D27 / 27

ADX (14)8

+DI / −DI16 / 20

RSI divergence—

MACD divergence—

ATR %+5.87%

ADR %5.33%

52w high9.83

52w low0.5499

From 52w high-52.75%

Above 52w low+744.70%

New 52w highNo

SqueezeOn · 33d

Bollinger width14.35%

%B0.24

Donchian pos15.03%

Donchian high5.47

Donchian low4.50

AVWAP (52w high)5.64

vs AVWAP high-17.57%

AVWAP (52w low)3.70

vs AVWAP low+25.56%

OBV trendDown

Chaikin MF (20)-0.11

Today vs 20d0.83×

Avg vol (14d)16.27K

Avg vol (20d)30.39K

Avg $ vol (20d)149.8K

Market cap5.79M

RS 3m (vs SPY)-0.05%

RS 6m (vs SPY)+334.79%

RS line new highNo

Trend template3/8

Technical rank63.6

1 week-3.23%

1 month-5.01%

3 months+4.97%

6 months+322.27%

1 year+34.25%

YTD-50.53%

P/E-0.22

P/B0.50

P/S1.86

P/FCF-0.23

EPS-87.27

Div yield—

ROE-223.62%

ROA-130.47%

Debt/Eq0.30

Current3.36

EV/EBITDA0.20

Gross margin—

Net margin-833.88%

Rev growth0.00%

EPS growth-7.61%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-5.28M

Revenue3.11M

Net income-6.7M

Gross profit—

Free cash flow-25.62M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out1.25M

Employees33

ListedWed, Jul 20, 2016

Free float1.18M

Float %99.9%

Short interest80.16K

Days to cover2.7d

Short volume14.6%

Squeeze score27 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction36 / 100

Pattern quality—

Tech rank63.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.54

Support4.29

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in APVO

All disclosures →

No recent disclosed trades by Congress in APVO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in APVO

No recent insider (Form 4) filings in APVO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in APVO · 1 recent

EDGAR →

13D/GSCHEDULE 13GMon, Jun 22, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.